nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketoprofen—PTGS2—bile duct cancer	0.946	1	CbGaD
Ketoprofen—Ketorolac—PTGS2—bile duct cancer	0.00145	0.109	CrCbGaD
Ketoprofen—Carprofen—PTGS2—bile duct cancer	0.00145	0.109	CrCbGaD
Ketoprofen—Bromfenac—PTGS2—bile duct cancer	0.00139	0.105	CrCbGaD
Ketoprofen—Tiaprofenic acid—PTGS2—bile duct cancer	0.00118	0.0889	CrCbGaD
Ketoprofen—Nepafenac—PTGS2—bile duct cancer	0.00113	0.0846	CrCbGaD
Ketoprofen—Magnesium salicylate—PTGS2—bile duct cancer	0.0011	0.0826	CrCbGaD
Ketoprofen—Fenbufen—PTGS2—bile duct cancer	0.00108	0.0809	CrCbGaD
Ketoprofen—Salsalate—PTGS2—bile duct cancer	0.000936	0.0703	CrCbGaD
Ketoprofen—CXCR1—lymph node—bile duct cancer	0.000918	0.15	CbGeAlD
Ketoprofen—Suprofen—PTGS2—bile duct cancer	0.000897	0.0674	CrCbGaD
Ketoprofen—Fenoprofen—PTGS2—bile duct cancer	0.000773	0.0581	CrCbGaD
Ketoprofen—Mefenamic acid—PTGS2—bile duct cancer	0.000717	0.0539	CrCbGaD
Ketoprofen—ALB—gall bladder—bile duct cancer	0.000705	0.116	CbGeAlD
Ketoprofen—Naproxen—PTGS2—bile duct cancer	0.000704	0.0529	CrCbGaD
Ketoprofen—CXCL8—pancreas—bile duct cancer	0.000668	0.109	CbGeAlD
Ketoprofen—Flurbiprofen—PTGS2—bile duct cancer	0.000504	0.0379	CrCbGaD
Ketoprofen—CXCL8—liver—bile duct cancer	0.000425	0.0696	CbGeAlD
Ketoprofen—CXCL8—Corticotropin-releasing hormone—GNAS—bile duct cancer	0.00039	0.0112	CbGpPWpGaD
Ketoprofen—PTGS2—gall bladder—bile duct cancer	0.000384	0.0629	CbGeAlD
Ketoprofen—CXCL8—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP9—bile duct cancer	0.000381	0.0109	CbGpPWpGaD
Ketoprofen—CXCL8—Bladder Cancer—EGFR—bile duct cancer	0.000355	0.0101	CbGpPWpGaD
Ketoprofen—SLC22A11—liver—bile duct cancer	0.000352	0.0577	CbGeAlD
Ketoprofen—CXCL8—ATF-2 transcription factor network—MMP2—bile duct cancer	0.000349	0.00999	CbGpPWpGaD
Ketoprofen—CXCL8—Senescence and Autophagy in Cancer—SMAD4—bile duct cancer	0.000345	0.00986	CbGpPWpGaD
Ketoprofen—SLC22A7—liver—bile duct cancer	0.000344	0.0563	CbGeAlD
Ketoprofen—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—bile duct cancer	0.000341	0.00977	CbGpPWpGaD
Ketoprofen—PTGS1—Eicosanoid Synthesis—PTGS2—bile duct cancer	0.000339	0.0097	CbGpPWpGaD
Ketoprofen—CXCL8—LPA receptor mediated events—MMP2—bile duct cancer	0.000327	0.00936	CbGpPWpGaD
Ketoprofen—CXCL8—lymph node—bile duct cancer	0.000326	0.0534	CbGeAlD
Ketoprofen—ABCC4—Platelet degranulation—HGF—bile duct cancer	0.000326	0.00932	CbGpPWpGaD
Ketoprofen—CXCL8—Syndecan-2-mediated signaling events—TGFB1—bile duct cancer	0.000321	0.00918	CbGpPWpGaD
Ketoprofen—ABCC4—pancreas—bile duct cancer	0.000315	0.0515	CbGeAlD
Ketoprofen—ABCC4—Response to elevated platelet cytosolic Ca2+—HGF—bile duct cancer	0.00031	0.00888	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism of lipids and lipoproteins—FAR2—bile duct cancer	0.000306	0.00876	CbGpPWpGaD
Ketoprofen—CXCL8—Bladder Cancer—TP53—bile duct cancer	0.000298	0.00852	CbGpPWpGaD
Ketoprofen—CXCL8—Bladder Cancer—HRAS—bile duct cancer	0.000285	0.00815	CbGpPWpGaD
Ketoprofen—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—bile duct cancer	0.000284	0.00811	CbGpPWpGaD
Ketoprofen—SLC22A7—Fluoropyrimidine Activity—TP53—bile duct cancer	0.000275	0.00788	CbGpPWpGaD
Ketoprofen—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—bile duct cancer	0.000274	0.00783	CbGpPWpGaD
Ketoprofen—ABCC4—NRF2 pathway—SLC5A5—bile duct cancer	0.000272	0.00778	CbGpPWpGaD
Ketoprofen—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—bile duct cancer	0.000271	0.00774	CbGpPWpGaD
Ketoprofen—CXCL8—Syndecan-2-mediated signaling events—HRAS—bile duct cancer	0.000253	0.00723	CbGpPWpGaD
Ketoprofen—CXCL8—IL-3 Signaling Pathway—TGFB1—bile duct cancer	0.000251	0.00718	CbGpPWpGaD
Ketoprofen—CXCR1—GPCR ligand binding—GNAS—bile duct cancer	0.000247	0.00707	CbGpPWpGaD
Ketoprofen—CXCL8—LPA receptor mediated events—MMP9—bile duct cancer	0.000246	0.00703	CbGpPWpGaD
Ketoprofen—CXCL8—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—bile duct cancer	0.000237	0.00677	CbGpPWpGaD
Ketoprofen—SLC22A11—SLC-mediated transmembrane transport—SLC5A5—bile duct cancer	0.000234	0.0067	CbGpPWpGaD
Ketoprofen—CXCL8—Spinal Cord Injury—NOS2—bile duct cancer	0.000234	0.00668	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—FAR2—bile duct cancer	0.000233	0.00666	CbGpPWpGaD
Ketoprofen—CXCL8—AP-1 transcription factor network—MMP9—bile duct cancer	0.000229	0.00655	CbGpPWpGaD
Ketoprofen—PTGS1—Overview of nanoparticle effects—IL6—bile duct cancer	0.000223	0.00637	CbGpPWpGaD
Ketoprofen—ABCC4—Fluoropyrimidine Activity—TP53—bile duct cancer	0.000222	0.00635	CbGpPWpGaD
Ketoprofen—ABCC4—NRF2 pathway—TGFBR2—bile duct cancer	0.000219	0.00627	CbGpPWpGaD
Ketoprofen—ABCC4—Ectoderm Differentiation—SMAD4—bile duct cancer	0.000217	0.0062	CbGpPWpGaD
Ketoprofen—CXCL8—Metabolism of proteins—MUC4—bile duct cancer	0.000215	0.00615	CbGpPWpGaD
Ketoprofen—CXCL8—Metabolism of proteins—MUC1—bile duct cancer	0.000215	0.00615	CbGpPWpGaD
Ketoprofen—SLC22A7—SLC-mediated transmembrane transport—SLC5A5—bile duct cancer	0.000213	0.00608	CbGpPWpGaD
Ketoprofen—SLCO1A2—liver—bile duct cancer	0.000208	0.0341	CbGeAlD
Ketoprofen—ALB—liver—bile duct cancer	0.000207	0.0339	CbGeAlD
Ketoprofen—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—bile duct cancer	0.000206	0.00588	CbGpPWpGaD
Ketoprofen—ABCC4—NRF2 pathway—HGF—bile duct cancer	0.000201	0.00576	CbGpPWpGaD
Ketoprofen—ABCC4—liver—bile duct cancer	0.0002	0.0328	CbGeAlD
Ketoprofen—CXCL8—LPA receptor mediated events—EGFR—bile duct cancer	0.000199	0.00568	CbGpPWpGaD
Ketoprofen—CXCL8—IL-3 Signaling Pathway—HRAS—bile duct cancer	0.000198	0.00565	CbGpPWpGaD
Ketoprofen—CXCL8—TSLP Signaling Pathway—IL6—bile duct cancer	0.000195	0.00559	CbGpPWpGaD
Ketoprofen—CXCL8—AP-1 transcription factor network—TGFB1—bile duct cancer	0.000189	0.0054	CbGpPWpGaD
Ketoprofen—PTGS1—Arachidonic acid metabolism—PTGS2—bile duct cancer	0.000188	0.00539	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—FAR2—bile duct cancer	0.000185	0.00529	CbGpPWpGaD
Ketoprofen—CXCL8—G alpha (i) signalling events—GNAS—bile duct cancer	0.000184	0.00527	CbGpPWpGaD
Ketoprofen—SLC22A8—SLC-mediated transmembrane transport—SLC5A5—bile duct cancer	0.000179	0.00511	CbGpPWpGaD
Ketoprofen—PTGS2—pancreas—bile duct cancer	0.000177	0.029	CbGeAlD
Ketoprofen—PTGS2—Overview of nanoparticle effects—IL6—bile duct cancer	0.000177	0.00505	CbGpPWpGaD
Ketoprofen—CXCL8—Spinal Cord Injury—PTGS2—bile duct cancer	0.000172	0.00491	CbGpPWpGaD
Ketoprofen—CXCL8—Allograft Rejection—TGFB1—bile duct cancer	0.000171	0.0049	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—RNF43—bile duct cancer	0.00017	0.00487	CbGpPWpGaD
Ketoprofen—CXCL8—ATF-2 transcription factor network—IL6—bile duct cancer	0.000163	0.00466	CbGpPWpGaD
Ketoprofen—CXCL8—Metabolism of proteins—MUC2—bile duct cancer	0.000163	0.00466	CbGpPWpGaD
Ketoprofen—CXCL8—LPA receptor mediated events—HRAS—bile duct cancer	0.00016	0.00456	CbGpPWpGaD
Ketoprofen—SLCO1A2—SLC-mediated transmembrane transport—SLC5A5—bile duct cancer	0.000159	0.00454	CbGpPWpGaD
Ketoprofen—ALB—lymph node—bile duct cancer	0.000159	0.026	CbGeAlD
Ketoprofen—CXCL8—AP-1 transcription factor network—TP53—bile duct cancer	0.000155	0.00444	CbGpPWpGaD
Ketoprofen—ABCC4—lymph node—bile duct cancer	0.000153	0.0251	CbGeAlD
Ketoprofen—CXCL8—Corticotropin-releasing hormone—TGFB1—bile duct cancer	0.000152	0.00434	CbGpPWpGaD
Ketoprofen—CXCL8—Spinal Cord Injury—MMP9—bile duct cancer	0.000151	0.00431	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—FAR2—bile duct cancer	0.00015	0.0043	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—FAR2—bile duct cancer	0.00015	0.00428	CbGpPWpGaD
Ketoprofen—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—bile duct cancer	0.000149	0.00427	CbGpPWpGaD
Ketoprofen—ALB—Platelet degranulation—HGF—bile duct cancer	0.000147	0.00422	CbGpPWpGaD
Ketoprofen—CYP2C8—liver—bile duct cancer	0.000145	0.0238	CbGeAlD
Ketoprofen—ABCC4—Platelet activation, signaling and aggregation—HGF—bile duct cancer	0.000144	0.00413	CbGpPWpGaD
Ketoprofen—CXCL8—AP-1 transcription factor network—IL6—bile duct cancer	0.000142	0.00407	CbGpPWpGaD
Ketoprofen—ALB—Response to elevated platelet cytosolic Ca2+—HGF—bile duct cancer	0.00014	0.00402	CbGpPWpGaD
Ketoprofen—CXCR1—GPCR downstream signaling—GNAS—bile duct cancer	0.00014	0.004	CbGpPWpGaD
Ketoprofen—CXCL8—Glucocorticoid receptor regulatory network—TP53—bile duct cancer	0.000137	0.00391	CbGpPWpGaD
Ketoprofen—CXCL8—Senescence and Autophagy in Cancer—TGFB1—bile duct cancer	0.000136	0.0039	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—FAR2—bile duct cancer	0.000136	0.0039	CbGpPWpGaD
Ketoprofen—ABCC4—Platelet degranulation—TGFB1—bile duct cancer	0.000133	0.0038	CbGpPWpGaD
Ketoprofen—CYP2C9—liver—bile duct cancer	0.000129	0.0212	CbGeAlD
Ketoprofen—SLCO1A2—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	0.000129	0.00368	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—GNAS—bile duct cancer	0.000127	0.00363	CbGpPWpGaD
Ketoprofen—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—bile duct cancer	0.000126	0.00362	CbGpPWpGaD
Ketoprofen—CXCL8—Glucocorticoid receptor regulatory network—IL6—bile duct cancer	0.000125	0.00358	CbGpPWpGaD
Ketoprofen—PTGS2—Aryl Hydrocarbon Receptor—NRAS—bile duct cancer	0.000124	0.00356	CbGpPWpGaD
Ketoprofen—CXCL8—Spinal Cord Injury—TGFB1—bile duct cancer	0.000124	0.00355	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—FAR2—bile duct cancer	0.000122	0.0035	CbGpPWpGaD
Ketoprofen—CXCL8—Spinal Cord Injury—EGFR—bile duct cancer	0.000122	0.00348	CbGpPWpGaD
Ketoprofen—CYP2C8—Arachidonic acid metabolism—PTGS2—bile duct cancer	0.000122	0.00348	CbGpPWpGaD
Ketoprofen—PTGS1—Selenium Micronutrient Network—PTGS2—bile duct cancer	0.00012	0.00343	CbGpPWpGaD
Ketoprofen—SLC22A11—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.000119	0.00341	CbGpPWpGaD
Ketoprofen—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—bile duct cancer	0.000118	0.00339	CbGpPWpGaD
Ketoprofen—PTGS2—Aryl Hydrocarbon Receptor—EGFR—bile duct cancer	0.000113	0.00324	CbGpPWpGaD
Ketoprofen—PTGS2—liver—bile duct cancer	0.000113	0.0185	CbGeAlD
Ketoprofen—CXCL8—Senescence and Autophagy in Cancer—TP53—bile duct cancer	0.000112	0.00321	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR ligand binding—GNAS—bile duct cancer	0.000112	0.00319	CbGpPWpGaD
Ketoprofen—SLC22A7—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	0.000108	0.00309	CbGpPWpGaD
Ketoprofen—CXCL8—Senescence and Autophagy in Cancer—HRAS—bile duct cancer	0.000107	0.00307	CbGpPWpGaD
Ketoprofen—PTGS2—Aryl Hydrocarbon Receptor—KRAS—bile duct cancer	0.000107	0.00306	CbGpPWpGaD
Ketoprofen—CXCL8—Toll-like Receptor Signaling Pathway—IL6—bile duct cancer	0.000105	0.00301	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—FAR2—bile duct cancer	0.000104	0.00297	CbGpPWpGaD
Ketoprofen—CXCL8—Senescence-Associated Secretory Phenotype (SASP)—IL6—bile duct cancer	0.000103	0.00294	CbGpPWpGaD
Ketoprofen—CXCL8—Senescence and Autophagy in Cancer—IL6—bile duct cancer	0.000103	0.00294	CbGpPWpGaD
Ketoprofen—PTGS2—Spinal Cord Injury—NOS2—bile duct cancer	0.000102	0.00293	CbGpPWpGaD
Ketoprofen—CXCL8—Spinal Cord Injury—TP53—bile duct cancer	0.000102	0.00292	CbGpPWpGaD
Ketoprofen—CYP2C9—Arachidonic acid metabolism—PTGS2—bile duct cancer	9.91e-05	0.00283	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	9.78e-05	0.0028	CbGpPWpGaD
Ketoprofen—CXCL8—Spinal Cord Injury—IL6—bile duct cancer	9.36e-05	0.00268	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—SMAD4—bile duct cancer	9.35e-05	0.00268	CbGpPWpGaD
Ketoprofen—SLC22A11—Transmembrane transport of small molecules—GNAS—bile duct cancer	9.26e-05	0.00265	CbGpPWpGaD
Ketoprofen—PTGS2—Aryl Hydrocarbon Receptor—HRAS—bile duct cancer	9.1e-05	0.0026	CbGpPWpGaD
Ketoprofen—SLC22A8—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	9.08e-05	0.0026	CbGpPWpGaD
Ketoprofen—PTGS1—lymph node—bile duct cancer	9.04e-05	0.0148	CbGeAlD
Ketoprofen—ABCC4—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	8.71e-05	0.00249	CbGpPWpGaD
Ketoprofen—PTGS2—lymph node—bile duct cancer	8.64e-05	0.0142	CbGeAlD
Ketoprofen—SLC22A7—Transmembrane transport of small molecules—GNAS—bile duct cancer	8.4e-05	0.0024	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—FAR2—bile duct cancer	8.23e-05	0.00236	CbGpPWpGaD
Ketoprofen—CXCL8—Regulation of toll-like receptor signaling pathway—IL6—bile duct cancer	8.21e-05	0.00235	CbGpPWpGaD
Ketoprofen—ABCC4—NRF2 pathway—TGFB1—bile duct cancer	8.2e-05	0.00235	CbGpPWpGaD
Ketoprofen—SLCO1A2—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	8.07e-05	0.00231	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—GNAS—bile duct cancer	7.82e-05	0.00224	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—TGFBR2—bile duct cancer	7.77e-05	0.00222	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	7.76e-05	0.00222	CbGpPWpGaD
Ketoprofen—ALB—SLC-mediated transmembrane transport—SLC5A5—bile duct cancer	7.76e-05	0.00222	CbGpPWpGaD
Ketoprofen—ALB—Selenium Micronutrient Network—PTGS2—bile duct cancer	7.7e-05	0.0022	CbGpPWpGaD
Ketoprofen—PTGS2—C-MYB transcription factor network—NRAS—bile duct cancer	7.68e-05	0.0022	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—RNF43—bile duct cancer	7.68e-05	0.0022	CbGpPWpGaD
Ketoprofen—SLC22A6—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	7.58e-05	0.00217	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—GNAS—bile duct cancer	7.5e-05	0.00214	CbGpPWpGaD
Ketoprofen—CXCL8—SIDS Susceptibility Pathways—IL6—bile duct cancer	7.49e-05	0.00214	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—HGF—bile duct cancer	7.45e-05	0.00213	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—SMAD4—bile duct cancer	7.36e-05	0.0021	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular Senescence—TP53—bile duct cancer	7.1e-05	0.00203	CbGpPWpGaD
Ketoprofen—SLC22A8—Transmembrane transport of small molecules—GNAS—bile duct cancer	7.06e-05	0.00202	CbGpPWpGaD
Ketoprofen—ABCC4—Transmembrane transport of small molecules—GNAS—bile duct cancer	6.77e-05	0.00194	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—FAR2—bile duct cancer	6.7e-05	0.00192	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—FAR2—bile duct cancer	6.66e-05	0.00191	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—IDH2—bile duct cancer	6.66e-05	0.0019	CbGpPWpGaD
Ketoprofen—PTGS2—C-MYB transcription factor network—KRAS—bile duct cancer	6.61e-05	0.00189	CbGpPWpGaD
Ketoprofen—PTGS2—Spinal Cord Injury—MMP9—bile duct cancer	6.6e-05	0.00189	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—HGF—bile duct cancer	6.54e-05	0.00187	CbGpPWpGaD
Ketoprofen—PTGS1—Selenium Micronutrient Network—IL6—bile duct cancer	6.53e-05	0.00187	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular Senescence—IL6—bile duct cancer	6.5e-05	0.00186	CbGpPWpGaD
Ketoprofen—ALB—Vitamin B12 Metabolism—IL6—bile duct cancer	6.49e-05	0.00186	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	6.32e-05	0.00181	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—GNAS—bile duct cancer	6.31e-05	0.0018	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	6.28e-05	0.0018	CbGpPWpGaD
Ketoprofen—SLCO1A2—Transmembrane transport of small molecules—GNAS—bile duct cancer	6.27e-05	0.00179	CbGpPWpGaD
Ketoprofen—ALB—Platelet degranulation—TGFB1—bile duct cancer	6.01e-05	0.00172	CbGpPWpGaD
Ketoprofen—SLC22A6—Transmembrane transport of small molecules—GNAS—bile duct cancer	5.89e-05	0.00169	CbGpPWpGaD
Ketoprofen—ABCC4—Platelet activation, signaling and aggregation—TGFB1—bile duct cancer	5.89e-05	0.00168	CbGpPWpGaD
Ketoprofen—ALB—Folate Metabolism—TP53—bile duct cancer	5.77e-05	0.00165	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—GNAS—bile duct cancer	5.73e-05	0.00164	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—IDH1—bile duct cancer	5.73e-05	0.00164	CbGpPWpGaD
Ketoprofen—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—bile duct cancer	5.72e-05	0.00164	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—NOS2—bile duct cancer	5.71e-05	0.00163	CbGpPWpGaD
Ketoprofen—PTGS2—C-MYB transcription factor network—HRAS—bile duct cancer	5.62e-05	0.00161	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—FAR2—bile duct cancer	5.45e-05	0.00156	CbGpPWpGaD
Ketoprofen—PTGS2—Spinal Cord Injury—TGFB1—bile duct cancer	5.44e-05	0.00156	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular responses to stress—TP53—bile duct cancer	5.37e-05	0.00154	CbGpPWpGaD
Ketoprofen—PTGS2—Spinal Cord Injury—EGFR—bile duct cancer	5.33e-05	0.00153	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—NRAS—bile duct cancer	5.3e-05	0.00152	CbGpPWpGaD
Ketoprofen—ALB—Folate Metabolism—IL6—bile duct cancer	5.28e-05	0.00151	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—bile duct cancer	5.24e-05	0.0015	CbGpPWpGaD
Ketoprofen—PTGS2—Selenium Micronutrient Network—IL6—bile duct cancer	5.18e-05	0.00148	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	5.14e-05	0.00147	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—IDH2—bile duct cancer	5.07e-05	0.00145	CbGpPWpGaD
Ketoprofen—CXCL8—Metabolism of proteins—MMP2—bile duct cancer	4.92e-05	0.00141	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular responses to stress—IL6—bile duct cancer	4.91e-05	0.00141	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—EGFR—bile duct cancer	4.83e-05	0.00138	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—RNF43—bile duct cancer	4.8e-05	0.00137	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—KRAS—bile duct cancer	4.56e-05	0.00131	CbGpPWpGaD
Ketoprofen—PTGS2—Spinal Cord Injury—TP53—bile duct cancer	4.48e-05	0.00128	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—IDH1—bile duct cancer	4.36e-05	0.00125	CbGpPWpGaD
Ketoprofen—ALB—Selenium Micronutrient Network—IL6—bile duct cancer	4.19e-05	0.0012	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—IDH1—bile duct cancer	4.13e-05	0.00118	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—ERBB2—bile duct cancer	4.12e-05	0.00118	CbGpPWpGaD
Ketoprofen—PTGS2—Spinal Cord Injury—IL6—bile duct cancer	4.1e-05	0.00117	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—IDH2—bile duct cancer	4.02e-05	0.00115	CbGpPWpGaD
Ketoprofen—ALB—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	3.94e-05	0.00113	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—HRAS—bile duct cancer	3.88e-05	0.00111	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—SLC5A5—bile duct cancer	3.78e-05	0.00108	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—IL6—bile duct cancer	3.71e-05	0.00106	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—bile duct cancer	3.7e-05	0.00106	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—bile duct cancer	3.63e-05	0.00104	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	3.54e-05	0.00101	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—GNAS—bile duct cancer	3.54e-05	0.00101	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—MMP9—bile duct cancer	3.53e-05	0.00101	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—TGFBR2—bile duct cancer	3.51e-05	0.001	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—IDH1—bile duct cancer	3.46e-05	0.000989	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—bile duct cancer	3.43e-05	0.000981	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—GNAS—bile duct cancer	3.38e-05	0.000968	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—HGF—bile duct cancer	3.37e-05	0.000964	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—SMAD4—bile duct cancer	3.32e-05	0.00095	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—IDH2—bile duct cancer	3.27e-05	0.000936	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—NRAS—bile duct cancer	3.27e-05	0.000934	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—IDH2—bile duct cancer	3.25e-05	0.000931	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—NRAS—bile duct cancer	3.13e-05	0.000896	CbGpPWpGaD
Ketoprofen—ALB—Transmembrane transport of small molecules—GNAS—bile duct cancer	3.06e-05	0.000876	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—bile duct cancer	3.05e-05	0.000872	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—TGFB1—bile duct cancer	3.04e-05	0.000868	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—GNAS—bile duct cancer	2.94e-05	0.00084	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—TGFB1—bile duct cancer	2.91e-05	0.000833	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—SLC5A5—bile duct cancer	2.87e-05	0.000822	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—EGFR—bile duct cancer	2.85e-05	0.000816	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—IDH1—bile duct cancer	2.81e-05	0.000805	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—KRAS—bile duct cancer	2.81e-05	0.000804	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—IDH1—bile duct cancer	2.8e-05	0.0008	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—KRAS—bile duct cancer	2.7e-05	0.000771	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	2.69e-05	0.00077	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—TGFB1—bile duct cancer	2.66e-05	0.000762	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—IDH2—bile duct cancer	2.66e-05	0.000762	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—NOS2—bile duct cancer	2.58e-05	0.000739	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—TP53—bile duct cancer	2.5e-05	0.000715	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—TP53—bile duct cancer	2.4e-05	0.000686	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—NRAS—bile duct cancer	2.39e-05	0.000685	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—HRAS—bile duct cancer	2.39e-05	0.000684	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—HRAS—bile duct cancer	2.29e-05	0.000656	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—IDH1—bile duct cancer	2.29e-05	0.000655	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—SLC5A5—bile duct cancer	2.28e-05	0.000653	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—GNAS—bile duct cancer	2.23e-05	0.000639	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—TGFBR2—bile duct cancer	2.19e-05	0.000628	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—IL6—bile duct cancer	2.19e-05	0.000627	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—EGFR—bile duct cancer	2.18e-05	0.000624	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—SMAD4—bile duct cancer	2.08e-05	0.000594	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—KRAS—bile duct cancer	2.06e-05	0.000589	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—ERBB2—bile duct cancer	1.86e-05	0.000532	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—SLC5A5—bile duct cancer	1.86e-05	0.000531	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—SLC5A5—bile duct cancer	1.85e-05	0.000528	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—GNAS—bile duct cancer	1.77e-05	0.000507	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—HRAS—bile duct cancer	1.75e-05	0.000501	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	1.74e-05	0.000498	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	1.73e-05	0.000495	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—IL6—bile duct cancer	1.68e-05	0.000479	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—MMP9—bile duct cancer	1.59e-05	0.000456	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—PTGS2—bile duct cancer	1.58e-05	0.000451	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—NOS2—bile duct cancer	1.55e-05	0.000442	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—SLC5A5—bile duct cancer	1.51e-05	0.000432	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—NRAS—bile duct cancer	1.48e-05	0.000423	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—GNAS—bile duct cancer	1.44e-05	0.000413	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—GNAS—bile duct cancer	1.43e-05	0.00041	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	1.42e-05	0.000405	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—NRAS—bile duct cancer	1.41e-05	0.000404	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—TGFB1—bile duct cancer	1.37e-05	0.000393	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—TGFB1—bile duct cancer	1.31e-05	0.000376	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—EGFR—bile duct cancer	1.29e-05	0.000368	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—KRAS—bile duct cancer	1.27e-05	0.000364	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—KRAS—bile duct cancer	1.22e-05	0.000348	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—PTGS2—bile duct cancer	1.2e-05	0.000343	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—GNAS—bile duct cancer	1.17e-05	0.000336	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—ERBB2—bile duct cancer	1.16e-05	0.000333	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—TP53—bile duct cancer	1.13e-05	0.000323	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—TP53—bile duct cancer	1.08e-05	0.000309	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—HRAS—bile duct cancer	1.08e-05	0.000309	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—HRAS—bile duct cancer	1.03e-05	0.000296	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—IL6—bile duct cancer	9.9e-06	0.000283	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—NRAS—bile duct cancer	8.85e-06	0.000253	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—TGFB1—bile duct cancer	8.22e-06	0.000235	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—EGFR—bile duct cancer	8.06e-06	0.000231	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PTGS2—bile duct cancer	7.75e-06	0.000222	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PTGS2—bile duct cancer	7.7e-06	0.00022	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—KRAS—bile duct cancer	7.61e-06	0.000218	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—HRAS—bile duct cancer	6.47e-06	0.000185	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PTGS2—bile duct cancer	6.3e-06	0.00018	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—IL6—bile duct cancer	6.19e-06	0.000177	CbGpPWpGaD
